US 11827883
Dosages and methods for delivering lipid formulated nucleic acid molecules
granted A61KA61K47/543A61K47/60
Quick answer
US patent 11827883 (Dosages and methods for delivering lipid formulated nucleic acid molecules) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K47/543, A61K47/60, A61K9/0019, A61K9/1271